Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Receivables (2020 - 2025)

Historic Change in Receivables for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to -$8.4 million.

  • LifeStance Health's Change in Receivables rose 714.29% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.1 million, marking a year-over-year decrease of 53902.7%. This contributed to the annual value of $6.4 million for FY2024, which is 7353.88% down from last year.
  • LifeStance Health's Change in Receivables amounted to -$8.4 million in Q3 2025, which was up 714.29% from -$10.9 million recorded in Q2 2025.
  • LifeStance Health's 5-year Change in Receivables high stood at $50.5 million for Q1 2024, and its period low was -$26.4 million during Q4 2024.
  • Its 5-year average for Change in Receivables is $2.8 million, with a median of $3.4 million in 2023.
  • Data for LifeStance Health's Change in Receivables shows a peak YoY increase of 48154.69% (in 2022) and a maximum YoY decrease of 46958.88% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows LifeStance Health's Change in Receivables stood at $3.5 million in 2021, then crashed by 469.59% to -$12.9 million in 2022, then crashed by 87.82% to -$24.3 million in 2023, then dropped by 8.44% to -$26.4 million in 2024, then skyrocketed by 68.09% to -$8.4 million in 2025.
  • Its last three reported values are -$8.4 million in Q3 2025, -$10.9 million for Q2 2025, and $8.6 million during Q1 2025.